Work

Phase II trial of topotecan, cisplatin, and bevacizumab for recurrent or persistent cervical cancer.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.5101

Authors: Israel Zighelboim, Jason D. Wright, Feng Gao, Ashley Stephens Case, L. Stewart Massad, David Gardner Mutch, Matthew A. Powell, Premal H. Thaker, Eric Lawernce Eisenhauer, David E. Cohn, Fidel A. Valea, Angeles Alvarez Secord, Lynne T. Lippmann, Janet Sue Rader

Institutions: Washington University in St. Louis, Columbia University, Hope Women's Cancer Centers, The Ohio State University, Duke Medical Center, Medical College of Wisconsin

Language: English

Topic: Endometrial and Cervical Cancer Treatments

Subfield: Obstetrics and Gynecology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590783779

Cites:

Cited by:

Related to: 10